Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorRyan J. Halter
About this trial
This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.
Eligibility criteria
Qualifiers
Clinical diagnosis of prostate cancer requiring RARP.
Ability to understand and the willingness to sign a written informed consent document.
Age ≥ 18 years old
Disqualifiers
Adults with implanted electrical devices such as pacemakers
Prisoners
Adults with impaired decision-making capacity
Any condition for which, in the opinion of the investigator, contraindicates study participation.
Trial design
Treatments tested in this trial
- custom device to demonstrate a significant difference in electrical impedance signatures
Treatment groups
No treatment groups listed
Sponsors and collaborators
Ryan J. Halter
Lead sponsor
Dartmouth-Hitchcock Medical Center
Sponsor institution
Dartmouth College
Collaborator
Source ClinicalTrials.gov